Randomized Double-Blind Crossover Study for Evaluating a Probiotic Mixture on Gastrointestinal and Behavioral Symptoms of Autistic Children.

ASD autism spectrum disorder autistic children behavioral symptoms gastrointestinal symptoms gut–brain axis microbiome analysis microbiota probiotics randomized double-blind crossover study

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
06 Sep 2022
Historique:
received: 13 07 2022
revised: 24 08 2022
accepted: 29 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

Autism spectrum disorders (ASDs) represent a diagnostic challenge with a still partially uncertain etiology, in which genetic and environmental factors have now been assessed. Among the hypotheses underlying the involvement of biological and environmental factors, the gut-brain axis is of particular interest in autism spectrum disorders. Several studies have highlighted the related incidence of particular gastrointestinal symptoms (GISs) in children suffering from ASDs. Probiotics have shown success in treating several gastrointestinal dysbiotic disorders; therefore, it is plausible to investigate whether they can alleviate behavioral symptoms as well. On these bases, a randomized double-blind crossover study with a placebo was conducted, evaluating the effects of a mixture of probiotics in a group of 61 subjects aged between 24 months and 16 years old with a diagnosis of ASD. Behavioral evaluation was performed through the administration of a questionnaire including a Parenting Stress Index (PSI) test and the Vineland Adaptive Behavior Scale (VABS). The Psycho-Educational Profile and the Autism Spectrum Rating Scale (ASRS) were also evaluated. Microbial composition analyses of fecal samples of the two groups was also performed. The study showed significant improvements in GISs, communication skills, maladaptive behaviors, and perceived parental stress level after the administration of probiotics. Microbiome alpha diversity was comparable between treatment arms and no significant differences were found, although beta diversity results were significantly different in the treatment group between T0 and T1 time points.

Identifiants

pubmed: 36142909
pii: jcm11185263
doi: 10.3390/jcm11185263
pmc: PMC9504504
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nutr Neurosci. 2018 Nov;21(9):676-681
pubmed: 28686541
Biol Psychiatry. 2018 Jan 15;83(2):148-159
pubmed: 28793975
FASEB J. 2014 Jul;28(7):3064-74
pubmed: 24719355
PLoS Comput Biol. 2017 Nov 3;13(11):e1005752
pubmed: 29099853
Adv Exp Med Biol. 2014;817:373-403
pubmed: 24997043
Int J Mol Sci. 2019 Apr 29;20(9):
pubmed: 31035684
Dig Liver Dis. 2016 Mar;48(3):248-54
pubmed: 26748423
Mycopathologia. 2017 Apr;182(3-4):349-363
pubmed: 27655151
PLoS One. 2019 Jan 9;14(1):e0210064
pubmed: 30625189
Gut Pathog. 2020 Feb 03;12:6
pubmed: 32025243
Anaerobe. 2017 Jun;45:133-137
pubmed: 28215985
Br J Psychiatry. 2016 Dec;209(6):498-503
pubmed: 27388569
Nature. 2012 Apr 04;485(7397):242-5
pubmed: 22495311
J Autism Dev Disord. 2017 Jun;47(6):1673-1681
pubmed: 28289979
Curr Mol Med. 2008 Jun;8(4):282-98
pubmed: 18537636
PLoS One. 2009;4(2):e4512
pubmed: 19223985
World J Gastroenterol. 2013 Mar 14;19(10):1527-40
pubmed: 23539674
Neuropsychopharmacology. 2013 Sep;38(10):1929-36
pubmed: 23575742
Cell. 2012 Mar 16;148(6):1258-70
pubmed: 22424233
Biol Psychiatry. 2017 Mar 1;81(5):411-423
pubmed: 27773355
Neurosci Lett. 2010 Mar 8;471(3):162-5
pubmed: 20097267
Pediatrics. 2010 Jan;125 Suppl 1:S1-18
pubmed: 20048083
Adv Exp Med Biol. 2014;817:73-113
pubmed: 24997030
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
PLoS One. 2013 Jul 03;8(7):e68322
pubmed: 23844187
World J Gastroenterol. 2016 Dec 14;22(46):10093-10102
pubmed: 28028357
Microbiome. 2017 Jan 23;5(1):10
pubmed: 28122648
J Transl Med. 2016 Oct 19;14(1):298
pubmed: 27756430
Nat Rev Neurosci. 2012 Oct;13(10):701-12
pubmed: 22968153
Int J Dev Neurosci. 2015 Jun;43:70-7
pubmed: 25862937
Semin Fetal Neonatal Med. 2016 Dec;21(6):410-417
pubmed: 27255860
Cell Mol Life Sci. 2019 Apr;76(7):1275-1297
pubmed: 30570672
Front Psychiatry. 2020 Sep 25;11:550593
pubmed: 33101079
Bioessays. 2014 Oct;36(10):933-9
pubmed: 25145752
Neuropsychobiology. 2002;46(2):76-84
pubmed: 12378124
Curr Dev Disord Rep. 2016 Mar;3(1):75-81
pubmed: 27398286
Autism Res. 2012 Jun;5(3):160-79
pubmed: 22495912
J Am Acad Child Adolesc Psychiatry. 2017 Jun;56(6):466-474
pubmed: 28545751
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
Front Psychiatry. 2019 Jul 17;10:473
pubmed: 31404299
J Physiol. 2017 Jan 15;595(2):489-503
pubmed: 27641441
Surgery. 2007 Apr;141(4):470-80
pubmed: 17383524
Trends Mol Med. 2014 Sep;20(9):509-18
pubmed: 24956966
Psychol Med. 2015 Feb;45(3):601-13
pubmed: 25108395
Sci Rep. 2017 Aug 11;7(1):7883
pubmed: 28801574
Transl Psychiatry. 2017 Mar 21;7(3):e1067
pubmed: 28323282
Nature. 2015 Feb 26;518(7540):S12-5
pubmed: 25715275
Pathol Biol (Paris). 2015 Feb;63(1):35-42
pubmed: 25468489
Mol Psychiatry. 2012 Apr;17(4):389-401
pubmed: 22143005
Brain Behav Immun. 2010 Jan;24(1):9-16
pubmed: 19481599
Front Psychiatry. 2014 Aug 04;5:53
pubmed: 25136320
Annu Rev Public Health. 2007;28:235-58
pubmed: 17367287
Autism Res. 2017 Sep;10(9):1567-1572
pubmed: 28401674
J Pediatr Neurosci. 2015 Oct-Dec;10(4):304-7
pubmed: 26962332
J Autism Dev Disord. 2006 Nov;36(8):1053-64
pubmed: 16845577
PLoS One. 2016 Aug 11;11(8):e0160169
pubmed: 27513472
Clin Ther. 2015 May 1;37(5):976-83
pubmed: 26046240
Physiol Rev. 2010 Jul;90(3):859-904
pubmed: 20664075
Nutrition. 2012 Feb;28(2):124-6
pubmed: 22079796
Int J Speech Lang Pathol. 2014 Apr;16(2):151-8
pubmed: 24001171
Cell Mol Gastroenterol Hepatol. 2018 Apr 12;6(2):133-148
pubmed: 30023410
BMC Gastroenterol. 2011 Mar 16;11:22
pubmed: 21410934
Nutrients. 2019 Feb 28;11(3):
pubmed: 30823414
Neuroscience. 1995 May;66(1):1-4
pubmed: 7637860
Microbiome. 2018 Aug 2;6(1):133
pubmed: 30071894
Acta Paediatr. 2018 Dec;107(12):2172-2178
pubmed: 30246890
Nat Rev Neurosci. 2011 Aug 19;12(9):524-38
pubmed: 21852800
Science. 2006 Jun 2;312(5778):1355-9
pubmed: 16741115

Auteurs

Cristina Guidetti (C)

Department of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.

Elena Salvini (E)

Department of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.

Maurizio Viri (M)

Department of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.

Francesca Deidda (F)

Probiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.

Angela Amoruso (A)

Probiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.

Annalisa Visciglia (A)

Probiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.

Lorenzo Drago (L)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Matteo Calgaro (M)

Department of Biotechnology, University of Verona, 37100 Verona, Italy.

Nicola Vitulo (N)

Department of Biotechnology, University of Verona, 37100 Verona, Italy.

Marco Pane (M)

Probiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.

Anna Claudia Caucino (AC)

Department of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.

Classifications MeSH